ID   HGD_HUMAN               Reviewed;         445 AA.
AC   Q93099; A8K417; B2R8Z0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   15-MAR-2017, entry version 167.
DE   RecName: Full=Homogentisate 1,2-dioxygenase;
DE            EC=1.13.11.5;
DE   AltName: Full=Homogentisate oxygenase;
DE   AltName: Full=Homogentisic acid oxidase;
DE   AltName: Full=Homogentisicase;
GN   Name=HGD; Synonyms=HGO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS HIS-80; AKU SER-230 AND
RP   GLY-300.
RX   PubMed=8782815; DOI=10.1038/ng0996-19;
RA   Fernandez-Canon J.M., Granadino B., Beltran-Valero de Bernabe D.,
RA   Renedo M., Fernandez-Ruiz E., Penalva M.A., Rodriguez de Cordoba S.;
RT   "The molecular basis of alkaptonuria.";
RL   Nat. Genet. 14:19-24(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT HIS-80.
RC   TISSUE=Liver;
RA   Ramos S., Hernandez M., Rozes A., Larruga J., Gonzalez P.,
RA   Cabrera V.M.;
RT   "Homogentisate 1,2-dioxygenase human cDNA sequence.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-80.
RX   PubMed=9244427; DOI=10.1006/geno.1997.4805;
RA   Granadino B., Beltran-Valero de Bernabe D., Fernandez-Canon J.M.,
RA   Penalva M.A., Rodriguez de Cordoba S.;
RT   "The human homogentisate 1,2-dioxygenase (HGO) gene.";
RL   Genomics 43:115-122(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-80.
RC   TISSUE=Kidney, and Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT HIS-80.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-80.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-98, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS), METAL-BINDING SITES, AND
RP   SUBUNIT.
RX   PubMed=10876237; DOI=10.1038/76756;
RA   Titus G.P., Mueller H.A., Burgner J., Rodriguez de Cordoba S.,
RA   Penalva M.A., Timm D.E.;
RT   "Crystal structure of human homogentisate dioxygenase.";
RL   Nat. Struct. Biol. 7:542-546(2000).
RN   [11]
RP   VARIANT AKU ARG-161.
RX   PubMed=9154114;
RA   Gehrig A., Schmidt S.R., Mueller C.R., Srsen S., Srsnova K., Kress W.;
RT   "Molecular defects in alkaptonuria.";
RL   Cytogenet. Cell Genet. 76:14-16(1997).
RN   [12]
RP   VARIANTS AKU ALA-42; GLY-97; GLY-153; ILE-189; THR-216; HIS-225;
RP   SER-227 AND VAL-368.
RX   PubMed=9529363; DOI=10.1086/301805;
RA   Beltran-Valero de Bernabe D., Granadino B., Chiarelli I., Porfirio B.,
RA   Mayatepek E., Aquaron R., Moore M.M., Festen J.J.M., Sanmarti R.,
RA   Penalva M.A., de Cordoba S.R.;
RT   "Mutation and polymorphism analysis of the human homogentisate 1, 2-
RT   dioxygenase gene in alkaptonuria patients.";
RL   Am. J. Hum. Genet. 62:776-784(1998).
RN   [13]
RP   VARIANT AKU LYS-168.
RX   PubMed=9630082;
RA   Higashino K., Liu W., Ohkawa T., Yamamoto T., Fukui K., Ohno M.,
RA   Imanishi H., Iwasaki A., Amuro Y., Hada T.;
RT   "A novel point mutation associated with alkaptonuria.";
RL   Clin. Genet. 53:228-229(1998).
RN   [14]
RP   VARIANTS AKU GLY-60; CYS-62; ASP-122; THR-230 AND GLU-291.
RX   PubMed=10205262; DOI=10.1086/302376;
RA   Beltran-Valero de Bernabe D., Jimenez F.J., Aquaron R.,
RA   Rodriguez de Cordoba S.;
RT   "Analysis of alkaptonuria (AKU) mutations and polymorphisms reveals
RT   that the CCC sequence motif is a mutational hot spot in the
RT   homogentisate 1,2 dioxygenase gene (HGO).";
RL   Am. J. Hum. Genet. 64:1316-1322(1999).
RN   [15]
RP   VARIANTS AKU PRO-25 AND VAL-368.
RC   TISSUE=Leukocyte;
RX   PubMed=10340975; DOI=10.1136/bjo.83.6.680;
RA   Felbor U., Mutsch Y., Grehn F., Mueller C.R., Kress W.;
RT   "Ocular ochronosis in alkaptonuria patients carrying mutations in the
RT   homogentisate 1,2-dioxygenase gene.";
RL   Br. J. Ophthalmol. 83:680-683(1999).
RN   [16]
RP   VARIANTS AKU PRO-25; ARG-161; SER-230; ARG-270; GLY-300 AND VAL-368.
RC   TISSUE=Lymphocyte;
RX   PubMed=10482952; DOI=10.1038/sj.ejhg.5200343;
RA   Mueller C.R., Fregin A., Srsen S., Srsnova K., Halliger-Keller B.,
RA   Felbor U., Seemanova E., Kress W.;
RT   "Allelic heterogeneity of alkaptonuria in Central Europe.";
RL   Eur. J. Hum. Genet. 7:645-651(1999).
RN   [17]
RP   VARIANTS AKU SER-330; VAL-368 AND ARG-371.
RX   PubMed=10594001;
RA   Beltran-Valero de Bernabe D., Peterson P., Luopajarvi K.,
RA   Matintalo P., Alho A., Konttinen Y., Krohn K.,
RA   Rodriguez de Cordoba S., Ranki A.;
RT   "Mutational analysis of the HGO gene in Finnish alkaptonuria
RT   patients.";
RL   J. Med. Genet. 36:922-923(1999).
RN   [18]
RP   VARIANTS AKU ALA-3; ALA-42; GLY-60; PRO-61; CYS-62; LEU-73; THR-92;
RP   ARG-97; PHE-120; TRP-120; VAL-122; ARG-123; PRO-137; LEU-158; ARG-161;
RP   ASP-168; LYS-168; ARG-183; GLY-187; TRP-217; LEU-225; SER-230;
RP   PRO-258; ARG-269; ARG-270; GLY-300; PRO-321; LEU-359; ARG-360;
RP   GLU-362; VAL-368; LEU-373 AND GLN-401.
RX   PubMed=19862842; DOI=10.1002/humu.21120;
RA   Vilboux T., Kayser M., Introne W., Suwannarat P., Bernardini I.,
RA   Fischer R., O'Brien K., Kleta R., Huizing M., Gahl W.A.;
RT   "Mutation spectrum of homogentisic acid oxidase (HGD) in
RT   alkaptonuria.";
RL   Hum. Mutat. 30:1611-1619(2009).
RN   [19]
RP   VARIANTS AKU ARG-33; PHE-44; ARG-115; PRO-116; ALA-123; ALA-152;
RP   LEU-169; GLY-178; GLY-197; SER-219; ASN-276; ALA-360; ARG-361 AND
RP   HIS-374.
RX   PubMed=23430897; DOI=10.1007/8904_2011_68;
RA   Zatkova A., Sedlackova T., Radvansky J., Polakova H., Nemethova M.,
RA   Aquaron R., Dursun I., Usher J.L., Kadasi L.;
RT   "Identification of 11 novel homogentisate 1,2 dioxygenase variants in
RT   alkaptonuria patients and establishment of a novel LOVD-based HGD
RT   mutation database.";
RL   JIMD Rep. 4:55-65(2012).
RN   [20]
RP   VARIANTS AKU SER-227 AND ASN-369.
RX   PubMed=21437689; DOI=10.1007/s00296-011-1868-0;
RA   Al-sbou M.;
RT   "Novel mutations in the homogentisate 1,2 dioxygenase gene identified
RT   in Jordanian patients with alkaptonuria.";
RL   Rheumatol. Int. 32:1741-1746(2012).
RN   [21]
RP   VARIANT AKU CYS-329.
RX   PubMed=23353776; DOI=10.1016/j.gene.2013.01.020;
RA   Yang Y.J., Guo J.H., Chen W.J., Zhao R., Tang J.S., Meng X.H.,
RA   Zhao L., Tu M., He X.Y., Wu L.Q., Zhu Y.M.;
RT   "First report of HGD mutations in a Chinese with alkaptonuria.";
RL   Gene 518:467-469(2013).
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-80, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   VARIANTS AKU LYS-13; ASN-18; ALA-42; GLN-53; ARG-115; PHE-120;
RP   ARG-123; ARG-161; LEU-169; ASN-171; GLY-197; SER-219; HIS-225;
RP   PRO-225; SER-230; PHE-245; ARG-270; ASN-276; GLY-300; ASP-337;
RP   LEU-359; ARG-360; ARG-361; VAL-368 AND HIS-374, AND VARIANT THR-172.
RX   PubMed=25681086; DOI=10.1007/8904_2014_380;
RA   Usher J.L., Ascher D.B., Pires D.E., Milan A.M., Blundell T.L.,
RA   Ranganath L.R.;
RT   "Analysis of HGD gene mutations in patients with alkaptonuria from the
RT   United Kingdom: identification of novel mutations.";
RL   JIMD Rep. 24:3-11(2015).
CC   -!- CATALYTIC ACTIVITY: Homogentisate + O(2) = 4-maleylacetoacetate.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875;
CC   -!- PATHWAY: Amino-acid degradation; L-phenylalanine degradation;
CC       acetoacetate and fumarate from L-phenylalanine: step 4/6.
CC   -!- SUBUNIT: Homohexamer arranged as a dimer of trimers.
CC       {ECO:0000269|PubMed:10876237}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-3907760, EBI-3907760;
CC       P54274:TERF1; NbExp=2; IntAct=EBI-3907760, EBI-710997;
CC   -!- TISSUE SPECIFICITY: Highest expression in the prostate, small
CC       intestine, colon, kidney and liver.
CC   -!- DISEASE: Alkaptonuria (AKU) [MIM:203500]: An autosomal recessive
CC       error of metabolism characterized by an increase in the level of
CC       homogentisic acid. The clinical manifestations are urine that
CC       turns dark on standing and alkalinization, black ochronotic
CC       pigmentation of cartilage and collagenous tissues, and spine
CC       arthritis. {ECO:0000269|PubMed:10205262,
CC       ECO:0000269|PubMed:10340975, ECO:0000269|PubMed:10482952,
CC       ECO:0000269|PubMed:10594001, ECO:0000269|PubMed:19862842,
CC       ECO:0000269|PubMed:21437689, ECO:0000269|PubMed:23353776,
CC       ECO:0000269|PubMed:23430897, ECO:0000269|PubMed:25681086,
CC       ECO:0000269|PubMed:8782815, ECO:0000269|PubMed:9154114,
CC       ECO:0000269|PubMed:9529363, ECO:0000269|PubMed:9630082}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the homogentisate dioxygenase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U63008; AAB16836.1; -; mRNA.
DR   EMBL; Z75048; CAA99340.1; -; mRNA.
DR   EMBL; AF000573; AAC51650.1; -; Genomic_DNA.
DR   EMBL; AF045167; AAC02698.1; -; mRNA.
DR   EMBL; AK290782; BAF83471.1; -; mRNA.
DR   EMBL; AK313563; BAG36337.1; -; mRNA.
DR   EMBL; AC126182; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC133474; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79524.1; -; Genomic_DNA.
DR   EMBL; BC071757; AAH71757.1; -; mRNA.
DR   CCDS; CCDS3000.1; -.
DR   RefSeq; NP_000178.2; NM_000187.3.
DR   UniGene; Hs.368254; -.
DR   PDB; 1EY2; X-ray; 2.30 A; A=1-445.
DR   PDB; 1EYB; X-ray; 1.90 A; A=1-445.
DR   PDBsum; 1EY2; -.
DR   PDBsum; 1EYB; -.
DR   ProteinModelPortal; Q93099; -.
DR   SMR; Q93099; -.
DR   BioGrid; 109329; 5.
DR   IntAct; Q93099; 6.
DR   MINT; MINT-3049945; -.
DR   STRING; 9606.ENSP00000283871; -.
DR   iPTMnet; Q93099; -.
DR   PhosphoSitePlus; Q93099; -.
DR   BioMuta; HGD; -.
DR   MaxQB; Q93099; -.
DR   PaxDb; Q93099; -.
DR   PeptideAtlas; Q93099; -.
DR   PRIDE; Q93099; -.
DR   DNASU; 3081; -.
DR   Ensembl; ENST00000283871; ENSP00000283871; ENSG00000113924.
DR   GeneID; 3081; -.
DR   KEGG; hsa:3081; -.
DR   UCSC; uc003edw.4; human.
DR   CTD; 3081; -.
DR   DisGeNET; 3081; -.
DR   GeneCards; HGD; -.
DR   GeneReviews; HGD; -.
DR   H-InvDB; HIX0003593; -.
DR   HGNC; HGNC:4892; HGD.
DR   HPA; HPA047374; -.
DR   HPA; HPA052359; -.
DR   MalaCards; HGD; -.
DR   MIM; 203500; phenotype.
DR   MIM; 607474; gene.
DR   neXtProt; NX_Q93099; -.
DR   OpenTargets; ENSG00000113924; -.
DR   Orphanet; 56; Alkaptonuria.
DR   PharmGKB; PA29268; -.
DR   eggNOG; KOG1417; Eukaryota.
DR   eggNOG; COG3508; LUCA.
DR   GeneTree; ENSGT00390000004601; -.
DR   HOGENOM; HOG000139824; -.
DR   HOVERGEN; HBG005965; -.
DR   InParanoid; Q93099; -.
DR   KO; K00451; -.
DR   OMA; FNTIGTI; -.
DR   OrthoDB; EOG091G11CO; -.
DR   PhylomeDB; Q93099; -.
DR   TreeFam; TF300490; -.
DR   BioCyc; MetaCyc:HS03728-MONOMER; -.
DR   BRENDA; 1.13.11.5; 2681.
DR   Reactome; R-HSA-71182; Phenylalanine and tyrosine catabolism.
DR   UniPathway; UPA00139; UER00339.
DR   ChiTaRS; HGD; human.
DR   EvolutionaryTrace; Q93099; -.
DR   GenomeRNAi; 3081; -.
DR   PRO; PR:Q93099; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000113924; -.
DR   CleanEx; HS_HGD; -.
DR   ExpressionAtlas; Q93099; baseline and differential.
DR   Genevisible; Q93099; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004411; F:homogentisate 1,2-dioxygenase activity; EXP:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006559; P:L-phenylalanine catabolic process; TAS:Reactome.
DR   GO; GO:0006572; P:tyrosine catabolic process; TAS:ProtInc.
DR   Gene3D; 2.60.120.10; -; 2.
DR   InterPro; IPR005708; Homogentis_dOase.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR011051; RmlC_Cupin.
DR   PANTHER; PTHR11056; PTHR11056; 1.
DR   Pfam; PF04209; HgmA; 1.
DR   SUPFAM; SSF51182; SSF51182; 1.
DR   TIGRFAMs; TIGR01015; hmgA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Dioxygenase;
KW   Disease mutation; Iron; Metal-binding; Oxidoreductase;
KW   Phenylalanine catabolism; Polymorphism; Reference proteome;
KW   Tyrosine catabolism.
FT   CHAIN         1    445       Homogentisate 1,2-dioxygenase.
FT                                /FTId=PRO_0000220240.
FT   METAL       335    335       Iron.
FT   METAL       341    341       Iron.
FT   METAL       371    371       Iron.
FT   MOD_RES      98     98       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     414    414       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O09173}.
FT   VARIANT       3      3       E -> A (in AKU; dbSNP:rs200412910).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073076.
FT   VARIANT      13     13       E -> K (in AKU).
FT                                {ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073077.
FT   VARIANT      18     18       D -> N (in AKU).
FT                                {ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073078.
FT   VARIANT      25     25       L -> P (in AKU).
FT                                {ECO:0000269|PubMed:10340975,
FT                                ECO:0000269|PubMed:10482952}.
FT                                /FTId=VAR_009618.
FT   VARIANT      33     33       Q -> R (in AKU).
FT                                {ECO:0000269|PubMed:23430897}.
FT                                /FTId=VAR_073079.
FT   VARIANT      42     42       E -> A (in AKU; dbSNP:rs373921680).
FT                                {ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:25681086,
FT                                ECO:0000269|PubMed:9529363}.
FT                                /FTId=VAR_005272.
FT   VARIANT      44     44       L -> F (in AKU).
FT                                {ECO:0000269|PubMed:23430897}.
FT                                /FTId=VAR_073080.
FT   VARIANT      53     53       R -> Q (in AKU; dbSNP:rs200808744).
FT                                {ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073081.
FT   VARIANT      60     60       W -> G (in AKU).
FT                                {ECO:0000269|PubMed:10205262,
FT                                ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_005273.
FT   VARIANT      61     61       L -> P (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073082.
FT   VARIANT      62     62       Y -> C (in AKU).
FT                                {ECO:0000269|PubMed:10205262,
FT                                ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_005274.
FT   VARIANT      73     73       F -> L (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073083.
FT   VARIANT      80     80       Q -> H (in dbSNP:rs2255543).
FT                                {ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8782815,
FT                                ECO:0000269|PubMed:9244427,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.6}.
FT                                /FTId=VAR_049353.
FT   VARIANT      92     92       P -> T (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073084.
FT   VARIANT      97     97       W -> G (in AKU).
FT                                {ECO:0000269|PubMed:9529363}.
FT                                /FTId=VAR_005275.
FT   VARIANT      97     97       W -> R (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073085.
FT   VARIANT     115    115       G -> R (in AKU; dbSNP:rs755734596).
FT                                {ECO:0000269|PubMed:23430897,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073086.
FT   VARIANT     116    116       L -> P (in AKU; dbSNP:rs569846003).
FT                                {ECO:0000269|PubMed:23430897}.
FT                                /FTId=VAR_073087.
FT   VARIANT     120    120       C -> F (in AKU; dbSNP:rs752153829).
FT                                {ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073088.
FT   VARIANT     120    120       C -> W (in AKU; dbSNP:rs149165166).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073089.
FT   VARIANT     122    122       A -> D (in AKU).
FT                                {ECO:0000269|PubMed:10205262}.
FT                                /FTId=VAR_005276.
FT   VARIANT     122    122       A -> V (in AKU; dbSNP:rs544956641).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073090.
FT   VARIANT     123    123       G -> A (in AKU; dbSNP:rs374473331).
FT                                {ECO:0000269|PubMed:23430897}.
FT                                /FTId=VAR_073091.
FT   VARIANT     123    123       G -> R (in AKU; dbSNP:rs564979861).
FT                                {ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073092.
FT   VARIANT     137    137       L -> P (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073093.
FT   VARIANT     152    152       G -> A (in AKU).
FT                                {ECO:0000269|PubMed:23430897}.
FT                                /FTId=VAR_073094.
FT   VARIANT     153    153       D -> G (in AKU; dbSNP:rs775274569).
FT                                {ECO:0000269|PubMed:9529363}.
FT                                /FTId=VAR_005277.
FT   VARIANT     158    158       P -> L (in AKU; dbSNP:rs375396766).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073095.
FT   VARIANT     161    161       G -> R (in AKU; loss of activity; most
FT                                prevalent mutation in Slovak and Czech
FT                                patients; dbSNP:rs28941783).
FT                                {ECO:0000269|PubMed:10482952,
FT                                ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:25681086,
FT                                ECO:0000269|PubMed:9154114}.
FT                                /FTId=VAR_005278.
FT   VARIANT     168    168       E -> D (in AKU; dbSNP:rs780173554).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073096.
FT   VARIANT     168    168       E -> K (in AKU; loss of activity;
FT                                dbSNP:rs375283568).
FT                                {ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:9630082}.
FT                                /FTId=VAR_009619.
FT   VARIANT     169    169       F -> L (in AKU; dbSNP:rs756134838).
FT                                {ECO:0000269|PubMed:23430897,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073097.
FT   VARIANT     171    171       K -> N (in AKU).
FT                                {ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073098.
FT   VARIANT     172    172       M -> T. {ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073099.
FT   VARIANT     178    178       E -> G (in AKU).
FT                                {ECO:0000269|PubMed:23430897}.
FT                                /FTId=VAR_073100.
FT   VARIANT     183    183       Q -> R (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073101.
FT   VARIANT     187    187       R -> G (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073102.
FT   VARIANT     189    189       S -> I (in AKU).
FT                                {ECO:0000269|PubMed:9529363}.
FT                                /FTId=VAR_005279.
FT   VARIANT     197    197       R -> G (in AKU).
FT                                {ECO:0000269|PubMed:23430897,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073103.
FT   VARIANT     216    216       I -> T (in AKU; dbSNP:rs767201131).
FT                                {ECO:0000269|PubMed:9529363}.
FT                                /FTId=VAR_005280.
FT   VARIANT     217    217       G -> W (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073104.
FT   VARIANT     219    219       N -> S (in AKU).
FT                                {ECO:0000269|PubMed:23430897,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073105.
FT   VARIANT     225    225       R -> H (in AKU; dbSNP:rs562853291).
FT                                {ECO:0000269|PubMed:25681086,
FT                                ECO:0000269|PubMed:9529363}.
FT                                /FTId=VAR_005281.
FT   VARIANT     225    225       R -> L (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073106.
FT   VARIANT     225    225       R -> P (in AKU; dbSNP:rs562853291).
FT                                {ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073107.
FT   VARIANT     227    227       F -> S (in AKU).
FT                                {ECO:0000269|PubMed:21437689,
FT                                ECO:0000269|PubMed:9529363}.
FT                                /FTId=VAR_005282.
FT   VARIANT     230    230       P -> S (in AKU; complete loss of
FT                                activity; dbSNP:rs28942100).
FT                                {ECO:0000269|PubMed:10482952,
FT                                ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:25681086,
FT                                ECO:0000269|PubMed:8782815}.
FT                                /FTId=VAR_005283.
FT   VARIANT     230    230       P -> T (in AKU).
FT                                {ECO:0000269|PubMed:10205262}.
FT                                /FTId=VAR_005284.
FT   VARIANT     245    245       V -> F (in AKU).
FT                                {ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073108.
FT   VARIANT     258    258       Q -> P (in AKU; dbSNP:rs759843592).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073109.
FT   VARIANT     269    269       H -> R (in AKU; dbSNP:rs756522409).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073110.
FT   VARIANT     270    270       G -> R (in AKU; dbSNP:rs120074174).
FT                                {ECO:0000269|PubMed:10482952,
FT                                ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_009620.
FT   VARIANT     276    276       K -> N (in AKU).
FT                                {ECO:0000269|PubMed:23430897,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073111.
FT   VARIANT     291    291       D -> E (in AKU; dbSNP:rs754428438).
FT                                {ECO:0000269|PubMed:10205262}.
FT                                /FTId=VAR_005285.
FT   VARIANT     300    300       V -> G (in AKU; dbSNP:rs120074170).
FT                                {ECO:0000269|PubMed:10482952,
FT                                ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:25681086,
FT                                ECO:0000269|PubMed:8782815}.
FT                                /FTId=VAR_005286.
FT   VARIANT     321    321       R -> P (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073112.
FT   VARIANT     329    329       F -> C (in AKU).
FT                                {ECO:0000269|PubMed:23353776}.
FT                                /FTId=VAR_073113.
FT   VARIANT     330    330       R -> S (in AKU; dbSNP:rs120074171).
FT                                {ECO:0000269|PubMed:10594001}.
FT                                /FTId=VAR_008744.
FT   VARIANT     337    337       N -> D (in AKU).
FT                                {ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073114.
FT   VARIANT     359    359       P -> L (in AKU; dbSNP:rs764037565).
FT                                {ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073115.
FT   VARIANT     360    360       G -> A (in AKU).
FT                                {ECO:0000269|PubMed:23430897}.
FT                                /FTId=VAR_073116.
FT   VARIANT     360    360       G -> R (in AKU; dbSNP:rs368717991).
FT                                {ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073117.
FT   VARIANT     361    361       G -> R (in AKU; dbSNP:rs765219004).
FT                                {ECO:0000269|PubMed:23430897,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073118.
FT   VARIANT     362    362       G -> E (in AKU).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073119.
FT   VARIANT     368    368       M -> V (in AKU; loss of activity;
FT                                dbSNP:rs120074173).
FT                                {ECO:0000269|PubMed:10340975,
FT                                ECO:0000269|PubMed:10482952,
FT                                ECO:0000269|PubMed:10594001,
FT                                ECO:0000269|PubMed:19862842,
FT                                ECO:0000269|PubMed:25681086,
FT                                ECO:0000269|PubMed:9529363}.
FT                                /FTId=VAR_005287.
FT   VARIANT     369    369       T -> N (in AKU; dbSNP:rs765912447).
FT                                {ECO:0000269|PubMed:21437689}.
FT                                /FTId=VAR_073120.
FT   VARIANT     371    371       H -> R (in AKU; dbSNP:rs120074172).
FT                                {ECO:0000269|PubMed:10594001}.
FT                                /FTId=VAR_008745.
FT   VARIANT     373    373       P -> L (in AKU; dbSNP:rs138558042).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073121.
FT   VARIANT     374    374       D -> H (in AKU).
FT                                {ECO:0000269|PubMed:23430897,
FT                                ECO:0000269|PubMed:25681086}.
FT                                /FTId=VAR_073122.
FT   VARIANT     401    401       E -> Q (in AKU; dbSNP:rs767159114).
FT                                {ECO:0000269|PubMed:19862842}.
FT                                /FTId=VAR_073123.
FT   CONFLICT    383    383       K -> R (in Ref. 4; BAF83471).
FT                                {ECO:0000305}.
FT   STRAND        6      8       {ECO:0000244|PDB:1EYB}.
FT   STRAND       14     17       {ECO:0000244|PDB:1EYB}.
FT   HELIX        36     38       {ECO:0000244|PDB:1EYB}.
FT   STRAND       40     47       {ECO:0000244|PDB:1EYB}.
FT   HELIX        53     55       {ECO:0000244|PDB:1EYB}.
FT   STRAND       58     65       {ECO:0000244|PDB:1EYB}.
FT   HELIX        85     87       {ECO:0000244|PDB:1EYB}.
FT   STRAND       95     97       {ECO:0000244|PDB:1EYB}.
FT   TURN        105    107       {ECO:0000244|PDB:1EYB}.
FT   TURN        112    115       {ECO:0000244|PDB:1EYB}.
FT   STRAND      116    123       {ECO:0000244|PDB:1EYB}.
FT   HELIX       125    127       {ECO:0000244|PDB:1EYB}.
FT   STRAND      131    138       {ECO:0000244|PDB:1EYB}.
FT   STRAND      144    161       {ECO:0000244|PDB:1EYB}.
FT   STRAND      163    167       {ECO:0000244|PDB:1EYB}.
FT   STRAND      170    174       {ECO:0000244|PDB:1EYB}.
FT   STRAND      178    182       {ECO:0000244|PDB:1EYB}.
FT   STRAND      188    191       {ECO:0000244|PDB:1EYB}.
FT   STRAND      193    205       {ECO:0000244|PDB:1EYB}.
FT   HELIX       214    216       {ECO:0000244|PDB:1EYB}.
FT   HELIX       224    226       {ECO:0000244|PDB:1EYB}.
FT   STRAND      227    230       {ECO:0000244|PDB:1EYB}.
FT   STRAND      238    249       {ECO:0000244|PDB:1EYB}.
FT   STRAND      252    260       {ECO:0000244|PDB:1EYB}.
FT   STRAND      265    271       {ECO:0000244|PDB:1EYB}.
FT   STRAND      275    278       {ECO:0000244|PDB:1EYB}.
FT   HELIX       279    281       {ECO:0000244|PDB:1EYB}.
FT   STRAND      288    291       {ECO:0000244|PDB:1EYB}.
FT   HELIX       295    298       {ECO:0000244|PDB:1EYB}.
FT   STRAND      299    304       {ECO:0000244|PDB:1EYB}.
FT   STRAND      311    318       {ECO:0000244|PDB:1EYB}.
FT   STRAND      320    323       {ECO:0000244|PDB:1EYB}.
FT   STRAND      326    328       {ECO:0000244|PDB:1EYB}.
FT   STRAND      340    347       {ECO:0000244|PDB:1EYB}.
FT   STRAND      362    365       {ECO:0000244|PDB:1EYB}.
FT   HELIX       375    383       {ECO:0000244|PDB:1EYB}.
FT   STRAND      389    392       {ECO:0000244|PDB:1EYB}.
FT   STRAND      396    404       {ECO:0000244|PDB:1EYB}.
FT   HELIX       410    415       {ECO:0000244|PDB:1EYB}.
SQ   SEQUENCE   445 AA;  49964 MW;  F99B51C134FFF965 CRC64;
     MAELKYISGF GNECSSEDPR CPGSLPEGQN NPQVCPYNLY AEQLSGSAFT CPRSTNKRSW
     LYRILPSVSH KPFESIDEGQ VTHNWDEVDP DPNQLRWKPF EIPKASQKKV DFVSGLHTLC
     GAGDIKSNNG LAIHIFLCNT SMENRCFYNS DGDFLIVPQK GNLLIYTEFG KMLVQPNEIC
     VIQRGMRFSI DVFEETRGYI LEVYGVHFEL PDLGPIGANG LANPRDFLIP IAWYEDRQVP
     GGYTVINKYQ GKLFAAKQDV SPFNVVAWHG NYTPYKYNLK NFMVINSVAF DHADPSIFTV
     LTAKSVRPGV AIADFVIFPP RWGVADKTFR PPYYHRNCMS EFMGLIRGHY EAKQGGFLPG
     GGSLHSTMTP HGPDADCFEK ASKVKLAPER IADGTMAFMF ESSLSLAVTK WGLKASRCLD
     ENYHKCWEPL KSHFTPNSRN PAEPN
//
